Literature DB >> 2810954

The histological assessment and evaluation of a 4 day subrenal capsule assay by the percentage inhibition of DNA/protein.

M Nishiyama1, M Hirono, S Takagami, R Kim, T Saeki, Y Kirihara, K Jinushi, E Yanagawa, T Toge, M Niimoto.   

Abstract

A four day subrenal capsule assay was investigated in order to determine its ability to clinically predict tumor chemosensitivity. To establish more objective and accurate evaluation criteria, a histological assessment and measurement of the DNA and protein content of excised tumor implants was conducted in ddY mice. The histological studies provided qualitative results concerning the percentage of cancer cells in the xenograft, the number of mitoses, the amount of necrosis, and the extent of lymphocytic infiltration. The DNA content was measured by a modified version of the Schmidt-Thannhauser-Schneider method and the protein content was estimated using the Bio-Rad protein assay. The percentage of cancer cells in the xenograft correlated poorly with the relative increase in tumor size, weight and the percentage inhibition of DNA/protein (per cent DNA/protein), however, the per cent DNA/protein correlated well with the clinical effects in 85.7 per cent of the tumors studied. Moreover, the histological assessment information was only consistent with those results obtained for per cent DNA/protein in the control group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810954     DOI: 10.1007/bf02471620

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  8 in total

1.  A method for the determination of desoxyribonucleic acid, ribonucleic acid, and phosphoproteins in animal tissues.

Authors:  G SCHMIDT; S J THANNHAUSER
Journal:  J Biol Chem       Date:  1945       Impact factor: 5.157

2.  Prediction of individual tumor chemosensitivity in subrenal capsule assay.

Authors:  M Nishiyama; Y Noso; N Hirabayashi; M Yamaguchi; T Toge; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1986-07

3.  The subrenal capsule assay (SRCA).

Authors:  A E Bogden; W R Cobb
Journal:  Eur J Cancer Clin Oncol       Date:  1986-09

4.  A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors.

Authors:  F A Levi; J P Blum; G Lemaigre; C Bourut; A Reinberg; G Mathé
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

5.  Improvements and limitations of the subrenal capsule assay for determining tumour sensitivity to cytostatic drugs.

Authors:  M B Edelstein; T Smink; D J Ruiter; W Visser; L M van Putten
Journal:  Eur J Cancer Clin Oncol       Date:  1984-12

6.  Evaluation of growth and histology of human tumor xenografts implanted under the renal capsule of immunocompetent and immunodeficient mice.

Authors:  J A Bennett; V A Pilon; R T MacDowell
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

7.  Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy.

Authors:  T W Griffin; A E Bogden; S D Reich; D Antonelli; R E Hunter; A Ward; D T Yu; H L Greene; M E Costanza
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

8.  The 6 day subrenal capsule assay is of no value with primary surgical explants from gastric cancer.

Authors:  D Cunningham; A Jack; D F McMurdo; M Soukop; C S McArdle; D C Carter; S B Kaye
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

  8 in total
  1 in total

1.  A Synbiotic with Tumor Necrosis Factor-α Inhibitory Activity Ameliorates Experimental Jejunoileal Mucosal Injury.

Authors:  Ryoki Takahashi; Takayasu Noguchi; Yoko Mizoguchi; Tadashi Shimoyama; Teruko Nakazawa; Tohru Ikuta
Journal:  Biomed Res Int       Date:  2018-05-10       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.